MORRISVILLE, N.C.--(BUSINESS WIRE)--Jan. 13, 2006--BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has retained The Investor Relations Group, Inc. (IRG), based in New York City, to serve as its financial relations and corporate communications firm. IRG's mandate will be to increase investor awareness of BDSI within the U.S. market by introducing the company and its management to pre-qualified investment professionals and both financial and trade publications. The company's retention of IRG is part of its continuing investor relations and communications efforts in the wake of its "follow on" public offering in October 2005. Dr. Mark A. Sirgo, President and CEO of BDSI, commented, "We made significant progress on our business plan during 2005, and we are now to the point where we need the support of a full-time investor relations firm to assist us in communicating news to our stockholders and to raise the profile of the company within the investment community. We are pleased to have hired IRG to represent us as we continue our evolution into a fully integrated specialty pharmaceutical company."
